Comparative Analysis of UnitedHealth and Bristol-Myers Squibb: Investor Insights
Explore the investment insights of UnitedHealth and Bristol-Myers, their dividend yields, regulatory challenges, and unique strategies for long-term growth.
CARsgen's Zevor-cel, a BCMA-Targeted CAR-T Therapy, Included in China's 2025 Innovative Drug Catalogue
CARsgen's BCMA-targeted CAR-T therapy, zevor-cel, gains inclusion in China's 2025 Innovative Drug Catalogue, enhancing access and reimbursement for treating relapsed/refractory multiple myeloma.